Joseph Cotroneo, MD
General Practice · Lansing, MINPI 1194828251
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $230 and has fallen 87.4% since, to $29 in 2025.
Across 24 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$98
- Urgo Medical North America, LLC$68
- Kerecis Limited$62
- Tactile Systems Technology Inc$62
- Penumbra, Inc.$42
- Mimedx Group, Inc.$35
- plus $109 from 7 others
What the payments were for
- Food & beverage$476100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $98 |
| Urgo Medical North America, LLC | 2 | $68 |
| Kerecis Limited | 2 | $62 |
| Tactile Systems Technology Inc | 2 | $62 |
| Penumbra, Inc. | 2 | $42 |
| Mimedx Group, Inc. | 2 | $35 |
| Aroa Biosurgery Incorporated | 1 | $20 |
| KCI USA, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Solventum Corporation | 1 | $16 |
| Next Science LLC | 1 | $15 |
| Cashflow Solutions, LLC | 2 | $13 |
| Organogenesis Inc. | 1 | $11 |
How this compares
$476 in reported general payments places this provider in the 65th percentile of 3,051 general practice providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Valerate | 19 | $265 |
| Gentamicin Sulfate | 12 | $247 |
| Clindamycin Hcl | 17 | $138 |
Paid to pharmacies, not to this prescriber.
Other general practice in Lansing
- Paul RashidLansing$41K
- Harold RothLansing$10K
- Brian SchaeferLansing$8K
- Anil PrasadTaylor$1.7M
- Sadeer DaoodDearborn$1.1M
- Shakib HalabuWest Bloomfield$1.1M
- Christian GrothAnn Arbor$283K
- Dennis FasbinderAnn Arbor$194K
- Kevin BoneSaginaw$125K
- David JulianiRochester Hills$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.